Order Total (1 Item Items):
Shipping Destination:
9780306455049 - Targeting of Drugs 5: Strategies for Oligonucleotide and Gene Delivery in Therapy: 290 Nato Science Series A:, 290 (13 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (13)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (8)
- As New, Fine or Near Fine (No further results match this refinement)
- Very Good or Good (2)
- Fair or Poor (No further results match this refinement)
- As Described (3)
Binding
- All Bindings
- Hardcover (13)
- Softcover (No further results match this refinement)
Collectible Attributes
- First Edition (No further results match this refinement)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (3)
- Not Print on Demand (13)
Language (1)
Free Shipping
Seller Location
Seller Rating
-
Targeting of Drugs 5: Strategies for Oligonucleotide and Gene Delivery in Therapy (Nato Science Series: A:) (v. 5)
Seller: Zubal-Books, Since 1961, Cleveland, OH, U.S.A.
Seller rating 5 out of 5 stars
Condition: Very Good. 214 pp., Hardcover, minor scuffing to front pastedown, small hand stamp to title page and rear endpaper else very good. - If you are reading this, this item is actually (physically) in our stock and ready for shipment once ordered. We are not bookjackers. Buyer is responsible for any additional duties, taxes, or fees required by recipient's country.
-
Targeting of Drugs 5: Strategies for Oligonucleotide and Gene Delivery in Therapy. Nato ASI Series A: Life Sciences, Vol. 290)
Seller: books4less (Versandantiquariat Petra Gros GmbH & Co. KG), Welling, Germany
Seller rating 5 out of 5 stars
gebundene Ausgabe. Condition: Gut. 206 Seiten Das hier angebotene Buch stammt aus einer teilaufgelösten wissenschaftlichen Bibliothek und trägt die entsprechenden Kennzeichnungen (Rückenschild, Instituts-Stempel.); Schnitt und Einband sind etwas staubschmutzig; der Buchzustand ist ansonsten ordentlich und dem Alter entsprechend gut. Das Buch ist auf ENGLISCH. Sprache: Englisch Gewicht in Gramm: 600.
-
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
-
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
-
Condition: Used. pp. vii + 206.
-
Condition: Used. pp. vii + 206.
-
Condition: Used. pp. vii + 206.
-
Targeting of Drugs 5: Strategies for Oligonucleotide and Gene Delivery in Therapy (NATO Science Series A:, 290)
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
£ 50.80
£ 11.98 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Targeting of Drugs 5
Language: English
Published by Kluwer Academic Publishers Group, 1997
ISBN 10: 0306455048 ISBN 13: 9780306455049
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Seller rating 5 out of 5 stars
Condition: New. Proceedings of a NATO ASI held in Cape Sounion, Greece, June 24-July 5, 1995 Series: NATO Science Series A. Num Pages: 214 pages, biography. BIC Classification: MJCM; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 244 x 170 x 14. Weight in Grams: 590. . 1997. Hardback. . . . .
-
Targeting of Drugs 5
Language: English
Published by Kluwer Academic Publishers Group, 1996
ISBN 10: 0306455048 ISBN 13: 9780306455049
Condition: New. Proceedings of a NATO ASI held in Cape Sounion, Greece, June 24-July 5, 1995 Series: NATO Science Series A. Num Pages: 214 pages, biography. BIC Classification: MJCM; MMG. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 244 x 170 x 14. Weight in Grams: 590. . 1997. Hardback. . . . . Books ship from the US and Ireland.
-
Hardcover. Condition: Brand New. 214 pages. 10.25x6.75x0.75 inches. In Stock.
-
Gebunden. Condition: New. Proceedings of a NATO ASI held in Cape Sounion, Greece, June 24-July 5, 1995 Gene Therapy for Inherited Genetic Disease Possibilities and Problems C. Coutelle. Gene Delivery and Therapy: The Case for Cystic Fibrosis E.W.F.W. Alton. Immune Resp.
-
Targeting of Drugs 5 : Strategies for Oligonucleotide and Gene Delivery in Therapy
Language: English
Published by Springer Us Nov 1996, 1996
ISBN 10: 0306455048 ISBN 13: 9780306455049
Buch. Condition: Neu. Neuware - TheNATO AdvancedStudiesInstituteseries'TargetingofDrugs'wasoriginatedin 1981. It is nowamajorinternationalforum,heldeverytwo yearsin CapeSounion,Greece,in whichthepresentandthefutureofthisimportantareaofresearch in drugdeliveryisdiscussed in greatdepth. PreviousASIsoftheseriesdealtwith drugcarriersofnaturalandsynthetic origin,theirinteractionswith thebiologicalmilieu, waysby whichthefunctionofdrugcarriers iscircumvented and,morerecently,with avarietyofapproaches to carrierdesignor modificationthatcontributeto optimalcarrierfunction. Thepresentbookcontainsthe proceedings ofthe8thNATO ASI, 'TargetingofDrugs:Strategies for Oligonucleotideand GeneDelivery in Therapy', held in CapeSounionduring24June-5 July 1995. Asthetitle implies,thebookdealswith avarietyofsystemsin termsoftheirability to transportnucleic acidsto targetareasin vitro andin vivo in waysthateffectivelymodify,supplement, correct, orcurtailthefunctionofgenesin therapy. Weexpressourappreciation to Mrs. ConchaPerringfor herassistance with the organizationoftheASI. TheASI washeldunderthesponsorship ofNATO ScientificAffairs Division andco-sponsored andgenerouslyfinancedby SmithKlineBeechamPharmaceuticals (KingofPrussia). Financialassistance wasalsoprovidedby SandozPharma(Baseland Athens),GeneMedicine (Houston,USA), ChironCorporation(Emeryville,USA), BYK GuldenLombergChemische (Konstanz,Gernlany),HelpSA(Athens,Greece),Avanti Polar Lipids Inc (Birmingham,USA), OxfordMolecular(Oxford,UK), Pfizer(Kent,UK), andAlza Corporation(PaloAlto, USA). GregoryGregoriadis BrendaMcCormack v CONTENTS Gene Therapy for Inherited Genetic Disease: Possibilities and Problems c. Coutelle Gene Delivery and Therapy: The Case for Cystic Fibrosis 15 E. W. F. W. Alton Immune Responses with Direct Gene Transfer: DNA Vaccines and 21 Implications for Gene Therapy H. L. Davis Oligonucleotides: Molecular Versions for Optimal Use in Vivo 31 E. Saison-Behmoaras, A. Van Aerschot, I. Duroux, C. Hendrix, C. Helene, and P. Herdewijn Retrovirus Vectors in Gene Therapy: Targeting to Specific Cells 45 AJ. Kingsman, Y. Bae, J. c. Griffiths, N. Kim, E. E. Ramsdale, G. Romano, Y. Soneoka, P. M. Cannon, and S. M. Kingsman Adenovirus as Vectors for Gene Therapy 53 M. G. Lee Receptor-Mediated Gene Delivery with Synthetic Virus-like Particles 67 E. Wagner, M. Cotten, and K. Zatloukal Controllable Gene Therapy: Recent Advances in Non-Viral Gene Delivery 79 A.
